Business
CBD Industry Leader Charlotte's Web Joins Historic Alliance ONE HEMP to Support FDA Regulation
CBD Industry Leader Charlotte's Web Joins Historic Alliance ONE HEMP to Support FDA Regulation ...
About this update from Charlotte's Web Holdings, Inc.
[{"type":"text","content":"\n \n \n \n CBD Industry Leader Charlotte's Web Joins Historic Alliance ONE HEMP to Support FDA Regulation\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n ONE HEMP Takes\n \n \n Landmark Step in Engaging Congress and FDA; Unveils Groundbreaking CBD Safety Study\n \n \n \n \n \n LOUISVILLE, Colo.\n \n \n ,\n \n \n Sept. 19, 2023\n \n \n /CNW/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. (\"Charlotte's Web\" or the \"Company\"), the industry pioneer and market leader in hemp-derived cannabidiol (CBD) products is proud to announce its founding membership in\n \n ONE HEMP\n \n , a coalition comprised of top CBD industry stakeholders to support Congress and the U.S. Food and Drug Administration (FDA) through a science and data-backed approach to arrive at sensible dietary supplement regulation.\n \n \n \n \n \n \n \n \n \n \n \"As leaders in the hemp-based CBD market that prioritize science, safety, and\n \n \n responsible commerce, we stand united with\n \n ONE HEMP\n \n to bring clarity and stability to the marketplace. The time for the CBD industry and Congress to act is long overdue,\"\n \n \n said\n \n Jared Stanley\n \n , Co-Founder and Chief Operating Officer of Charlotte's Web\n \n . \"\n \n A decade has passed since hemp-based CBD became a wellness choice for more than 45 million daily American CBD consumers*. Over these ten years, rigorous scientific research, innovation, safety, and toxicology studies, current Good Manufacturing Practices, labeling standards, and valuable consumer feedback have demonstrated the self-regulation that responsible CBD suppliers have implemented to scaffold an entirely new industry.\"\n \n \n \n \n \n Mr. Stanley continued\n \n \n \n , \"Today, the uncertainty faced by thousands of companies and American farmers coupled with the confusion for millions of CBD consumers is unacceptable. It is time for Congress\n \n \n to clarify the FDA's mandate\n \n \n and definitively regulate CBD products as dietary supplements once and for all.\n \n...